Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | FDPS | P14324 | 3/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2130926 | 0.90 | SMPD1 (0.44) | SMPD1LMNATSHRGPR84FDPS | |
| SCHEMBL755748 | 0.90 | SMPD1 (0.44) | SMPD1LMNATSHRGPR84FDPS | |
| SCHEMBL13687268 | 0.90 | SMPD1 (0.44) | SMPD1LMNATSHRGPR84FDPS | |
| SCHEMBL13687283 | 0.90 | SMPD1 (0.44) | SMPD1LMNATSHRGPR84FDPS | |
| SCHEMBL2453033 | 0.90 | SMPD1 (0.44) | SMPD1LMNATSHRGPR84FDPS | |
| SCHEMBL36477 | 0.88 | SMPD1 (0.41) | SMPD1LMNATSHRFDPSMAPT | |
| SCHEMBL13686628 | 0.82 | TSHR (0.40) | SMPD1TSHR | |
| SCHEMBL6762424 | 0.77 | OPRM1 (0.37) | SMPD1LMNATSHR | |
| Cyclohexane SCHEMBL6913821 | 0.76 | GPR84 (0.36) | SMPD1LMNAGPR84SPHK1FFAR1 | |
| SCHEMBL2574114 | 0.75 | LMNA (0.53) | LMNATSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004084963-A1 | POROUS MEDICAL ADHESIVE COMPRISING CYANONACRYLATE | SMITH & NEPHEW, PLC (GB) | 2004-10-07 | — | — | WO | disclosed |